Jian-Guo Chen

Jian-Guo Chen

Auto-generated profile, based on publicly available information

Jian-Guo Chen

State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2012 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
BJBo Jiang
Bo Jiang
ZXZhe Xiong
Zhe Xiong
JYJun Yang
Jun Yang
WWWei Wang
Wei Wang
YWYue Wang
Yue Wang
JCJian‐Guo Chen
Jian‐Guo Chen
BACKGROUND AND PURPOSE Ginsenoside Rg1 (Rg1) is one of the major bioactive ingredients of Panax ginseng with little toxicity and has been shown to have neuroprotective effects. In this study, we investigated the antidepressant‐like effect of Rg1 in models of depression in mice.EXPERIMENTAL APPROACH The effects of Rg1 were assessed in the forced swimming test (FST) and tail suspension test (TST) in mice. Rg1 was also investigated in the chronic mild stress (CMS) mouse model of depression with imipramine as the positive control. Changes in hippocampal neurogenesis and spine density, the brain‐derived neurotrophic factor (BDNF) signalling pathway, and serum corticosterone level after chronic stress and Rg1 treatment were then investigated. The tryptophan hydroxylase inhibitor and the tyrosine kinase B inhibitor were also used to explore the antidepressive mechanisms of Rg1.KEY RESULTS Ginsenoside Rg1 exhibited antidepressant‐like activity in the FST and TST in mice without affecting locomotor activity. It was also effective in the CMS model of depression. Furthermore, Rg1 up‐regulated the BDNF signalling pathway in the hippocampus and down‐regulated serum corticosterone level during the CMS procedure. In addition, Rg1 was able to reverse the decrease in dendritic spine density and hippocampal neurogenesis caused by CMS. However, Rg1 had no discernable effect on the monoaminergic system.CONCLUSIONS AND IMPLICATIONS Our results provide the first evidence that Rg1 has antidepressant activity via activation of the BDNF signalling pathway and up‐regulation of hippocampal neurogenesis.

18 April 2017 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MLM-X Li
M-X Li
HZH-L Zheng
H-L Zheng
YLY Luo
Y Luo
JHJ-G He
J-G He
WWW Wang
W Wang
FWF Wang
F Wang
Both inflammatory processes and glutamatergic systems have been implicated in the pathophysiology of mood-related disorders. However, the role of caspase-1, a classic inflammatory caspase, in behavioral responses to chronic stress remains largely unknown. To address this issue, we examined the effects and underlying mechanisms of caspase-1 on preclinical murine models of depression. We found that loss of caspase-1 expression in Caspase-1−/− knockout mice alleviated chronic stress-induced depression-like behaviors, whereas overexpression of caspase-1 in the hippocampus of wild-type (WT) mice was sufficient to induce depression- and anxiety-like behaviors. Furthermore, chronic stress reduced glutamatergic neurotransmission and decreased surface expression of glutamate receptors in hippocampal pyramidal neurons of WT mice, but not Caspase-1−/− mice. Importantly, pharmacological inhibition of caspase-1-interleukin-1β (IL-1β) signaling pathway prevented the depression-like behaviors and the decrease in surface expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) in stressed WT mice. Finally, the effects of chronic stress on both depression- and anxiety-like behaviors can be mimicked by exogenous intracerebroventricular (i.c.v.) administration of IL-1β in both WT and Caspase-1−/− mice. Taken together, our findings demonstrate that an increase in the caspase-1/IL-1β axis facilitates AMPAR internalization in the hippocampus, which dysregulates glutamatergic synaptic transmission, eventually resulting in depression-like behaviors. These results may represent an endophenotype for chronic stress-induced depression.

3 December 2010 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PWPeng-Fei Wu
Peng-Fei Wu
ZZZui Zhang
Zui Zhang
FWFang Wang
Fang Wang
JCJian-Guo Chen
Jian-Guo Chen

15 July 2010 in Glia
Verified
Journal Article
Closed access
PDF file
CHChao Huang
Chao Huang
ZHZhuang‐Li Hu
Zhuang‐Li Hu
WWWen‐Ning Wu
Wen‐Ning Wu
DYDan‐Fang Yu
Dan‐Fang Yu
QXQiu‐Ju Xiong
Qiu‐Ju Xiong
JCJian‐Guo Chen
Jian‐Guo Chen

4 April 2012 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
YLYan-Kun Li
Yan-Kun Li
FWFang Wang
Fang Wang
WWWei Wang
Wei Wang
YLYi Luo
Yi Luo
PWPeng-Fei Wu
Peng-Fei Wu
JCJian-Guo Chen
Jian-Guo Chen
Astrocytes are implicated in information processing, signal transmission, and regulation of synaptic plasticity. Aquaporin-4 (AQP4) is the major water channel in adult brain and is primarily expressed in astrocytes. A growing body of evidence indicates that AQP4 is a potential molecular target for the regulation of astrocytic function. However, little is known about the role of AQP4 in synaptic plasticity in the amygdala. Therefore, we evaluated long-term potentiation (LTP) in the lateral amygdala (LA) and associative fear memory of AQP4 knockout (KO) and wild-type mice. We found that AQP4 deficiency impaired LTP in the thalamo-LA pathway and associative fear memory. Furthermore, AQP4 deficiency significantly downregulated glutamate transporter-1 (GLT-1) expression and selectively increased NMDA receptor (NMDAR)-mediated EPSCs in the LA. However, low concentration of NMDAR antagonist reversed the impairment of LTP in KO mice. Upregulating GLT-1 expression by chronic treatment with ceftriaxone also reversed the impairment of LTP and fear memory in KO mice. These findings imply a role for AQP4 in synaptic plasticity and associative fear memory in the amygdala by regulating GLT-1 expression.

6 April 2009 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
LMLi-Min Mao
Li-Min Mao
WWWei Wang
Wei Wang
Xiang-Ping ChuXiang-Ping Chu
Xiang-Ping Chu
GZGuo-Chi Zhang
Guo-Chi Zhang
XLXian-Yu Liu
Xian-Yu Liu
JWJohn Q Wang
John Q Wang
This study shows that chronic amphetamine exposure in rats downregulates the NMDA receptor NR2B subunit on striatal neurons. This loss of NR2B has consequences for synaptic transmission and for behavior, sensitizing the rats to the stimulant. Plastic changes in glutamatergic synapses that lead to endurance of drug craving and addiction are poorly understood. We examined the turnover and trafficking of NMDA receptors and found that chronic exposure to the psychostimulant amphetamine (AMPH) induced selective downregulation of NMDA receptor NR2B subunits in the confined surface membrane pool of rat striatal neurons at synaptic sites. This downregulation was a long-lived event and was a result of the destabilization of surface-expressed NR2B caused by accelerated ubiquitination and degradation of crucial NR2B-anchoring proteins by the ubiquitin-proteasome system. The biochemical loss of synaptic NR2B further translated to the modulation of synaptic plasticity in the form of long-term depression at cortico-accumbal glutamatergic synapses. Behaviorally, genetic disruption of NR2B induced and restoration of NR2B loss prevented behavioral sensitization to AMPH. Our data identify NR2B as an important regulator in the remodeling of excitatory synapses and persistent psychomotor plasticity in response to AMPH.